Antibodies to streptococcus pneumoniae capsular polysaccharide enhance pneumococcal quorum sensing

mBio

Volumn 2, Issue 5, 2011, Pages

  Yano, Masahide ^a   Gohil, Shruti ^a   Coleman, J Robert ^a   Manix, Catherine ^a   Pirofski, Liise anne ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; OPSONIN; PNEUMOCOCCUS POLYSACCHARIDE;

ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL GENE; BACTERICIDAL ACTIVITY; BACTERIUM TRANSFORMATION; BLP GENE; CELL KILLING; COM GENE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENE TRANSFER; IMMUNITY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; QUORUM SENSING; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); MUS; STREPTOCOCCUS PNEUMONIAE;

EID: 80455132055     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00176-11     Document Type: Article

References (34)

1. Whitney CG, et al. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:1737-1746.
2. Croucher NJ, et al. 2011. Rapid pneumococcal evolution in response to clinical interventions. Science 331:430-434.
3. Jackson LA, et al. 2003. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N. Engl. J. Med. 348:1747-1755.
4. Weinberger DM, et al. 2010. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin. Infect. Dis. 51: 692-699.
5. Jackson LA, Janoff EN. 2008. Pneumococcal vaccination of elderly adults: new paradigms for protection. Clin. Infect. Dis. 47:1328-1338.
6. Robbins JB, Schneerson R, Szu SC. 1995. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1387-1398.
7. Romero-Steiner S, et al. 1997. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.
8. Fabrizio K, Groner A, Boes M, Pirofski LA. 2007. A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infection. Clin. Vaccine Immunol. 14: 382-390.
9. Tian H, Weber S, Thorkildson P, Kozel TR, Pirofski LA. 2009. Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice. Infect. Immun. 77: 1502-1513.
10. Burns T, Zhong Z, Steinitz M, Pirofski LA. 2003. Modulation of poly-morphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharide. Infect. Immun. 71:6775-6783.
11. Fabrizio K, Manix C, Guimaraes AJ, Nosanchuk JD, Pirofski LA. 2010. Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo. Clin. Vaccine Immunol. 17:713-721.
12. Håvarstein LS, Martin B, Johnsborg O, Granadel C, Claverys JP. 2006. New insights into the pneumococcal fratricide: relationship to clumping and identification of a novel immunity factor. Mol. Microbiol. 59: 1297-1307.
13. Oggioni MR, et al. 2004. Antibacterial activity of a competence-stimulating peptide in experimental sepsis caused by Streptococcus pneu-moniae. Antimicrob. Agents Chemother. 48:4725-4732.
14. Khajanchi BK, Kirtley ML, Brackman SM, Chopra AK. 2011. Immuno-modulatory and protective roles of quorum-sensing signaling molecules N-acyl homoserine lactones during infection of mice with Aeromonas hy-drophila. Infect. Immun. 79:2646-2657.
15. Porat N, et al. 2008. An international serotype 3 clone causing pediatric noninvasive infectionsin Israel, Costa Rica, and Lithuania. Pediatr. Infect. Dis. J. 27: 709-712.
16. Yano M, Pirofski LA. 2011. Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8. Clin. Vaccine Immunol. 18:59-66.
17. Luo P, Morrison DA. 2003. Transient association of an alternative sigma factor, ComX, with RNA polymerase during the period of competence for genetic transformation in Streptococcus pneumoniae. J. Bacteriol. 185: 349-358.
18. Claverys JP, Prudhomme M, Martin B. 2006. Induction of competence regulons as a general response to stress in gram-positive bacteria. Annu. Rev. Microbiol. 60:451-475.
19. Reichmann P, Hakenbeck R. 2000. Allelic variation in a peptide-inducible two-component system of Streptococcus pneumoniae. FEMS Mi-crobiol. Lett. 190:231-236.
20. Dawid S, Sebert ME, Weiser JN. 2009. Bacteriocin activity of Streptococcus pneumoniae is controlled by the serine protease HtrA via posttran-scriptional regulation. J. Bacteriol. 191:1509-1518.
21. Prudhomme M, Attaiech L, Sanchez G, Martin B, Claverys JP. 2006. Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae. Science 313:89-92.
22. Rogers PD, et al. 2007. Gene expression profiling of the response of Streptococcus pneumoniae to penicillin. J. Antimicrob. Chemother. 59: 616-626.
23. McClelland EE, Nicola AM, Prados-Rosales R, Casadevall A. 2010. Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. J. Clin. Invest. 120:1355-1361.
24. Martin B, Quentin Y, Fichant G, Claverys JP. 2006. Independent evolution of competence regulatory cascades in streptococci? Trends Micro-biol. 14:339-345.
25. Kmetzsch L, et al. 2011. Role for Golgi reassembly and stacking protein (GRASP) in polysaccharide secretion and fungal virulence. Mol. Micro-biol. 81:206-218.
26. Taborda CP, Casadevall A. 2002. CR3 (CD11b/CD18) and CR4 (CD11c/ CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 16:791-802.
27. Torosantucci A, et al. 2005. A novel glyco-conjugate vaccine against fungal pathogens. J. Exp. Med. 202:597-606.
28. McDaniel LS, Scott G, Kearney JF, Briles DE. 1984. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J. Exp. Med. 160: 386-397.
29. Burns T, Abadi M, Pirofski LA. 2005. Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human im-munoglobulinMmonoclonal antibody to serotype8 capsular polysaccha-ride. Infect. Immun. 73:4530-4538.
30. Coleman JR, Papamichail D, Yano M, Garcia-Suarez MD, Pirofski LA. 2011. Designed reduction of Streptococcus pneumoniae pathogenicity via synthetic changes in virulence factor codon-pair bias. J. Infect. Dis. 203: 1264-1273.
31. Kumar R, et al. 2010. Identification of novel non-coding small RNAs from Streptococcus pneumoniae TIGR4 using high-resolution genome tiling arrays. BMC Genomics 11:350.
32. Feng J, et al. 2009. Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance. Genome Res. 19:1214-1223.
33. Chang Q, Zhong Z, Lees A, Pekna M, Pirofski L. 2002. Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin loci. Infect. Immun. 70:4977-4986.
34. Maitta RW, et al. 2004. Protective and nonprotective human immuno-globulin M monoclonal antibodies to Cryptococcus neoformans glucuron-oxylomannan manifest different specificities and gene use profiles. Infect. Immun. 72:4810-4818.